Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

Ejemplares similares

• Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System”
  por: Trumbo, Henry, et al.
  Publicado: (2021)
• Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
  por: Dores, Graça M., et al.
  Publicado: (2019)
• Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
  por: Kato, Yamato, et al.
  Publicado: (2015)
• Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
  por: Learned, Christine, et al.
  Publicado: (2022)
• Prevention of adverse events in the administration of drugs
  por: Diano, G, et al.
  Publicado: (2010)